226 related articles for article (PubMed ID: 12717071)
1. 99mTc-MIBI scintigraphy in untreated stage III multiple myeloma: comparison with X-ray skeletal survey and bone scintigraphy.
Alper E; Gurel M; Evrensel T; Ozkocaman V; Akbunar T; Demiray M
Nucl Med Commun; 2003 May; 24(5):537-42. PubMed ID: 12717071
[TBL] [Abstract][Full Text] [Related]
2. Value of Tc-99m sestamibi scintigraphy in the detection of bone lesions in multiple myeloma: comparison with Tc-99m methylene diphosphonate.
Alexandrakis MG; Kyriakou DS; Passam F; Koukouraki S; Karkavitsas N
Ann Hematol; 2001 Jun; 80(6):349-53. PubMed ID: 11475149
[TBL] [Abstract][Full Text] [Related]
3. Different patterns of technetium-99m sestamibi uptake in multiple myeloma.
Pace L; Catalano L; Pinto A; De Renzo A; Di Gennaro F; Califano C; Del Vecchio S; Rotoli B; Salvatore M
Eur J Nucl Med; 1998 Jul; 25(7):714-20. PubMed ID: 9662593
[TBL] [Abstract][Full Text] [Related]
4. Technetium-99m 2-methoxy-isobutyl-isonitrile uptake scintigraphy in detection of the bone marrow infiltration in multiple myeloma: correlation with MRI and other prognostic factors.
Erten N; Saka B; Berberoglu K; Turkmen C; Unal S; Bakir B; Yekeler E; Besisik SK
Ann Hematol; 2007 Nov; 86(11):805-13. PubMed ID: 17684742
[TBL] [Abstract][Full Text] [Related]
5. Technetium-99m sestamibi scintigraphy is sensitive and specific for the staging and the follow-up of patients with multiple myeloma: a multicentre study on 397 scans.
Mele A; Offidani M; Visani G; Marconi M; Cambioli F; Nonni M; Catarini M; Brianzoni E; Berbellini A; Ascoli G; Brunori M; Agostini V; Corvatta L; Isidori A; Spinelli A; Gradari M; Leoni P
Br J Haematol; 2007 Mar; 136(5):729-35. PubMed ID: 17233770
[TBL] [Abstract][Full Text] [Related]
6. Technetium-99m-sestamibi scintigraphy in multiple myeloma and related gammopathies: a useful tool for the identification and follow-up of myeloma bone disease.
Balleari E; Villa G; Garrè S; Ghirlanda P; Agnese G; Carletto M; Clavio M; Ferrando F; Gobbi M; Mariani G; Ghio R
Haematologica; 2001 Jan; 86(1):78-84. PubMed ID: 11146575
[TBL] [Abstract][Full Text] [Related]
7. Comparison of whole-body 18F-FDG PET, 99mTc-MIBI SPET, and post-therapeutic 131I-Na scintigraphy in the detection of metastatic thyroid cancer.
Iwata M; Kasagi K; Misaki T; Matsumoto K; Iida Y; Ishimori T; Nakamoto Y; Higashi T; Saga T; Konishi J
Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):491-8. PubMed ID: 14666387
[TBL] [Abstract][Full Text] [Related]
8. Staging and therapy monitoring of multiple myeloma by 99mTc-sestamibi scintigraphy: a five year single center experience.
Villa G; Balleari E; Carletto M; Grosso M; Clavio M; Piccardo A; Rebella L; Tommasi L; Morbelli S; Peschiera F; Gobbi M; Ghio R
J Exp Clin Cancer Res; 2005 Sep; 24(3):355-61. PubMed ID: 16270521
[TBL] [Abstract][Full Text] [Related]
9. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M
J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma.
Fonti R; Del Vecchio S; Zannetti A; De Renzo A; Di Gennaro F; Catalano L; Califano C; Pace L; Rotoli B; Salvatore M
Eur J Nucl Med; 2001 Feb; 28(2):214-20. PubMed ID: 11303893
[TBL] [Abstract][Full Text] [Related]
11. Scintigraphy with technetium-99m methoxyisobutylisonitrile in multiple myeloma patients: correlation with the International Staging System.
Koutsikos J; Grigoraki V; Athanasoulis T; Velidaki A; Mamoulakis C; Zomas A; Anagnostopoulos N; Georgiou E; Dimopoulos MA; Zerva C
Hell J Nucl Med; 2006; 9(3):177-80. PubMed ID: 17160159
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of technetium-99m sestamibi in patients with multiple myeloma and potential role in the follow-up.
Pace L; Catalano L; Del Vecchio S; Di Gennaro F; De Renzo A; Sica G; Califano C; Tedesco N; Borrelli G; Rotoli B; Salvatore M
Eur J Nucl Med; 2001 Mar; 28(3):304-12. PubMed ID: 11315597
[TBL] [Abstract][Full Text] [Related]
13. Potential of (99m)Tc-MIBI for detecting bone marrow metastases.
Wakasugi S; Noguti A; Katuda T; Hashizume T; Hasegawa Y
J Nucl Med; 2002 May; 43(5):596-602. PubMed ID: 11994520
[TBL] [Abstract][Full Text] [Related]
14. The role of 99Tcm-sestamibi scintigraphy in the staging and prediction of the therapeutic response of stage IV neuroblastoma: comparison with 131I-MIBG and 99Tcm-MDP scintigraphy.
Burak Z; Yüksel DA; Cetingül N; Kantar M; Ozkiliç H; Moretti JL
Nucl Med Commun; 1999 Nov; 20(11):991-1000. PubMed ID: 10572908
[TBL] [Abstract][Full Text] [Related]
15. Comparative whole-body 201Tl and bone scintigraphies for the detection of bone marrow involvement in multiple myeloma.
Nishiyama Y; Yamamoto Y; Nagai M; Satoh K; Ohkawa M
Nucl Med Commun; 2003 Sep; 24(9):977-86. PubMed ID: 12960597
[TBL] [Abstract][Full Text] [Related]
16. [18F-FDG PET/CT and 99mTc-MIBI scintigraphy in evaluation of patients with multiple myeloma and monoclonal gammopathy of unknown significance: comparison of methods].
Myslivecek M; Bacovský J; Scudla V; Koranda P; Minarík J; Buriánková E; Formánek R; Zapletalová J
Klin Onkol; 2010; 23(5):325-31. PubMed ID: 21061682
[TBL] [Abstract][Full Text] [Related]
17. Multiple myeloma: predictive value of Tc-99m MIBI scintigraphy and MRI in its diagnosis and therapy.
Myslivecek M; Nekula J; Bacovsky J; Scudla V; Koranda P; Kaminek M
Nucl Med Rev Cent East Eur; 2008; 11(1):12-6. PubMed ID: 19173182
[TBL] [Abstract][Full Text] [Related]
18. A comparison of fluorine-18 fluoro-deoxyglucose PET and technetium-99m sestamibi in assessing patients with multiple myeloma.
Mileshkin L; Blum R; Seymour JF; Patrikeos A; Hicks RJ; Prince HM
Eur J Haematol; 2004 Jan; 72(1):32-7. PubMed ID: 14962260
[TBL] [Abstract][Full Text] [Related]
19. The value of 99mTc-MIBI whole body scintigraphy in active and in remission multiple myeloma.
Fallahi B; Saghari M; Fard Esfahani A; Eftekhari M; Iravani M; Beiki D; Dabbagh Kakhki VR; Sadeghi R
Hell J Nucl Med; 2005; 8(3):165-8. PubMed ID: 16390023
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow immunoscintigraphy using technetium-99m anti-granulocyte antibody in multiple myeloma.
Sohn SK; Ahn BC; Lee SW; Kim DH; Chun KA; Kim JG; Park SH; Song HS; Lee B; Lee J
Eur J Nucl Med Mol Imaging; 2002 May; 29(5):591-6. PubMed ID: 11976796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
